861 related articles for article (PubMed ID: 10368677)
21. Epstein-Barr virus in Reed-Sternberg-like cells in non-Hodgkin's lymphomas.
Khan G; Norton AJ; Slavin G
J Pathol; 1993 Jan; 169(1):9-14. PubMed ID: 8381864
[TBL] [Abstract][Full Text] [Related]
22. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
23. Decreased number of granzyme B+ activated CD8+ cytotoxic T lymphocytes in the inflammatory background of HIV-associated Hodgkin's lymphoma.
Bosch Príncep R; Lejeune M; Salvadó Usach MT; Jaén Martínez J; Pons Ferré LE; Alvaro Naranjo T
Ann Hematol; 2005 Oct; 84(10):661-6. PubMed ID: 15875183
[TBL] [Abstract][Full Text] [Related]
24. Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease.
Vermeer MH; Geelen FA; Kummer JA; Meijer CJ; Willemze R
Am J Pathol; 1999 Apr; 154(4):1203-10. PubMed ID: 10233858
[TBL] [Abstract][Full Text] [Related]
25. T-cell-rich large-B-cell lymphomas contain non-activated CD8+ cytolytic T cells, show increased tumor cell apoptosis, and have lower Bcl-2 expression than diffuse large-B-cell lymphomas.
Felgar RE; Steward KR; Cousar JB; Macon WR
Am J Pathol; 1998 Dec; 153(6):1707-15. PubMed ID: 9846961
[TBL] [Abstract][Full Text] [Related]
26. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
27. Clinical, immunohistochemical and phenotypic features of aggressive nodal cytotoxic lymphomas, including alpha/beta, gamma/delta T-cell and natural killer cell types.
Ohshima K; Suzumiya J; Sugihara M; Kanda M; Shimazaki K; Kawasaki C; Haraoka S; Kikuchi M
Virchows Arch; 1999 Aug; 435(2):92-100. PubMed ID: 10599306
[TBL] [Abstract][Full Text] [Related]
28. Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells.
Alvaro T; Lejeune M; Salvadó MT; Bosch R; García JF; Jaén J; Banham AH; Roncador G; Montalbán C; Piris MA
Clin Cancer Res; 2005 Feb; 11(4):1467-73. PubMed ID: 15746048
[TBL] [Abstract][Full Text] [Related]
29. Correlation of immunophenotype of sinonasal non-Hodgkin's lymphoma to Epstein-Barr virus infection.
Feng YF; Wu QL; Zong YS
Ai Zheng; 2007 Nov; 26(11):1170-6. PubMed ID: 17991313
[TBL] [Abstract][Full Text] [Related]
30. Cytotoxic molecule expression is predictive of prognosis in Hodgkin's-like anaplastic large cell lymphoma.
Asano N; Suzuki R; Matsuo K; Kagami Y; Ishida F; Tamaru JI; Jin GS; Sato Y; Shimoyama Y; Yoshino T; Morishima Y; Nakamura S
Histopathology; 2007 May; 50(6):705-15. PubMed ID: 17493234
[TBL] [Abstract][Full Text] [Related]
31. Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?
Bladergroen BA; Meijer CJ; ten Berge RL; Hack CE; Muris JJ; Dukers DF; Chott A; Kazama Y; Oudejans JJ; van Berkum O; Kummer JA
Blood; 2002 Jan; 99(1):232-7. PubMed ID: 11756176
[TBL] [Abstract][Full Text] [Related]
32. Differential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8+ and CD56+ cutaneous lymphomas.
Kamarashev J; Burg G; Mingari MC; Kempf W; Hofbauer G; Dummer R
Am J Pathol; 2001 May; 158(5):1593-8. PubMed ID: 11337356
[TBL] [Abstract][Full Text] [Related]
33. Expression of vascular endothelial growth factor in lymphomas and Castleman's disease.
Foss HD; Araujo I; Demel G; Klotzbach H; Hummel M; Stein H
J Pathol; 1997 Sep; 183(1):44-50. PubMed ID: 9370946
[TBL] [Abstract][Full Text] [Related]
34. NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status.
Ko YH; Cho EY; Kim JE; Lee SS; Huh JR; Chang HK; Yang WI; Kim CW; Kim SW; Ree HJ
Histopathology; 2004 May; 44(5):480-9. PubMed ID: 15139996
[TBL] [Abstract][Full Text] [Related]
35. High incidence of EBV genome in CD30-positive non-Hodgkin's lymphomas.
Kanavaros P; Jiwa NM; de Bruin PC; van der Valk P; Noorduyn LA; van Heerde P; Gordijn R; Horstman A; Mullink R; Willemze R
J Pathol; 1992 Nov; 168(3):307-15. PubMed ID: 1335046
[TBL] [Abstract][Full Text] [Related]
36. Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive and -negative cases of Hodgkin's disease.
Dukers DF; Jaspars LH; Vos W; Oudejans JJ; Hayes D; Cillessen S; Middeldorp JM; Meijer CJ
J Pathol; 2000 Feb; 190(2):143-9. PubMed ID: 10657011
[TBL] [Abstract][Full Text] [Related]
37. Clusterin expression in malignant lymphomas: a survey of 266 cases.
Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
[TBL] [Abstract][Full Text] [Related]
38. [Expression of latent membrane protein (LMP) in large-cell anaplastic lymphomas].
Gonzalo I; Santón A; Manzanal A; Marcos B; Ageitos A; Bellas C; Rivas C
Sangre (Barc); 1995 Aug; 40(4):289-92. PubMed ID: 7482117
[TBL] [Abstract][Full Text] [Related]
39. CD40 expression in Hodgkin's disease.
O'Grady JT; Stewart S; Lowrey J; Howie SE; Krajewski AS
Am J Pathol; 1994 Jan; 144(1):21-6. PubMed ID: 7507299
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin.
Krenacs L; Wellmann A; Sorbara L; Himmelmann AW; Bagdi E; Jaffe ES; Raffeld M
Blood; 1997 Feb; 89(3):980-9. PubMed ID: 9028330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]